Extracellular Matrix Remodeling During Palate Development

References

• Li C, Lan Y, Jiang R. Molecular and cellular mechanisms of palate development. J Dent Res. 2017;96:1184–91. doi:10.1177/0022034517703580.
   PubMed Web of Science ®Google Scholar
• Lan Y, Xu J, Jiang R. Cellular and molecular mechanisms of palatogenesis. Curr Top Dev Biol. 2015;115:59–84.
   PubMed Web of Science ®Google Scholar
• Hynes RO, Naba A. Overview of the matrisome–an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. 2012;4:a004903. doi:10.1101/cshperspect.a004903.
   PubMed Web of Science ®Google Scholar
• Hynes RO. The extracellular matrix: not just pretty fibrils. Science (New York, NY). 2009;326:1216–19. doi:10.1126/science.1176009.
   Google Scholar
• Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15:786–801. doi:10.1038/nrm3904.
   PubMed Web of Science ®Google Scholar
• d’Amaro R, Scheidegger R, Blumer S, Pazera P, Katsaros C, Graf D, Chiquet M. Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. Front Physiol. 2012;3:377.
   PubMed Web of Science ®Google Scholar
• Oka K, Honda MJ, Tsuruga E, Hatakeyama Y, Isokawa K, Sawa Y. Roles of collagen and periostin expression by cranial neural crest cells during soft palate development. J Histochem Cytochem. 2012;60:57–68. doi:10.1369/0022155411427059.
   PubMed Web of Science ®Google Scholar
• Xu J, Huang Z, Wang W, Tan X, Li H, Zhang Y, Tian W, Hu T, Chen YP. FGF8 signaling alters the osteogenic cell fate in the hard palate. J Dent Res. 2018;97:589–96. doi:10.1177/0022034517750141.
   PubMed Web of Science ®Google Scholar
• Lan Y, Zhang N, Liu H, Xu J, Jiang R. Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. Development. 2016;143:2344–55. doi:10.1242/dev.134577.
   PubMed Web of Science ®Google Scholar
• Ferguson MW. Palate development. Development. 1988;103:Suppl:41–60.
   PubMed Web of Science ®Google Scholar
• Vaziri Sani F, Kaartinen V, El Shahawy M, Linde A, Gritli-Linde A. Developmental changes in cellular and extracellular structural macromolecules in the secondary palate and in the nasal cavity of the mouse. Eur J Oral Sci. 2010;118:221–36. doi:10.1111/j.1600-0722.2010.00732.x.
   PubMed Web of Science ®Google Scholar
• Enomoto H, Nelson CM, Somerville RP, Mielke K, Dixon LJ, Powell K, Apte SS. Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation. Development. 2010;137:4029–38. doi:10.1242/dev.050591.
   PubMed Web of Science ®Google Scholar
• Ibrahim I, Serrano MJ, Ruest LB, Svoboda KKH. Biglycan and decorin expression and distribution in palatal adhesion. J Dent Res. 2017;96:1445–50. doi:10.1177/0022034517722783.
   PubMed Web of Science ®Google Scholar
• Ida-Yonemochi H, Morita W, Sugiura N, Kawakami R, Morioka Y, Takeuchi Y, Sato T, Shibata S, Watanabe H, Imamura T, et al. Craniofacial abnormality with skeletal dysplasia in mice lacking chondroitin sulfate N-acetylgalactosaminyltransferase-1. Sci Rep. 2018;8:17134. doi:10.1038/s41598-018-35412-5.
   PubMed Web of Science ®Google Scholar
• Nik AM, Johansson JA, Ghiami M, Reyahi A, Carlsson P. Foxf2 is required for secondary palate development and Tgfbeta signaling in palatal shelf mesenchyme. Dev Biol. 2016;415:14–23. doi:10.1016/j.ydbio.2016.05.013.
   PubMed Web of Science ®Google Scholar
• Li L, Shi JY, Zhu GQ, Shi B. MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells. J Cell Biochem. 2012;113:1235–44. doi:10.1002/jcb.23457.
   PubMed Web of Science ®Google Scholar
• Martinez-Sanz E, Del Rio A, Barrio C, Murillo J, Maldonado E, Garcillan B, Amorós M, Fuerte T, Fernández Á, Trinidad E, et al. Alteration of medial-edge epithelium cell adhesion in two Tgf-beta3 null mouse strains. Differentiation. 2008;76:417–30. doi:10.1111/j.1432-0436.2007.00226.x.
   PubMed Web of Science ®Google Scholar
• Gato A, Martinez ML, Tudela C, Alonso I, Moro JA, Formoso MA, Ferguson MWJ, Martı́nez-Álvarez C. TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion. Dev Biol. 2002;250:393–405. doi:10.1006/dbio.2002.0792.
   PubMed Web of Science ®Google Scholar
• Mienaltowski MJ, Birk DE. Structure, physiology, and biochemistry of collagens. Adv Exp Med Biol. 2014;802:5–29.
   PubMed Web of Science ®Google Scholar
• Silver MH, Foidart JM, Pratt RM. Distribution of fibronectin and collagen during mouse limb and palate development. Differentiation. 1981;18:141–49. doi:10.1111/j.1432-0436.1981.tb01115.x.
   PubMed Web of Science ®Google Scholar
• Kurisu K, Ohsaki Y, Nagata K, Kukita T, Yoshikawa H, Inai T. Immunocytochemical demonstration of simultaneous synthesis of types I, III and V collagen and fibronectin in mouse embryonic palatal mesenchymal cells in vitro. Coll Relat Res. 1987;7:333–40. doi:10.1016/S0174-173X(87)80026-2.
   PubMedGoogle Scholar
• Kurisu K, Ohsaki Y, Nagata K, Inai T, Kukita T. Heterogeneous distribution of the precursor of type I and type III collagen and fibronectin in the rough endoplasmic reticulum of palatal mesenchymal cells of the mouse embryo cultured in ascorbate-depleted medium. Cell Tissue Res. 1992;267:429–35. doi:10.1007/BF00319365.
   PubMed Web of Science ®Google Scholar
• Ohsaki Y, Nagata K, Kurisu K. Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. Acta Anat. 1995;153:161–67. doi:10.1159/000147696.
   PubMedGoogle Scholar
• Gagliano N, Carinci F, Moscheni C, Torri C, Pezzetti F, Scapoli L, Martinelli M, Gioia M, Stabellini G. New insights in collagen turnover in orofacial cleft patients. Cleft Palate-Craniofacial J. 2010;47:393–99. doi:10.1597/07-196.1.
   PubMed Web of Science ®Google Scholar
• Fantauzzo KA, Soriano P. PDGFRbeta regulates craniofacial development through homodimers and functional heterodimers with PDGFRalpha. Genes Dev. 2016;30:2443–58. doi:10.1101/gad.288746.116.
   PubMed Web of Science ®Google Scholar
• Higuchi Y, Hasegawa K, Yamashita M, Tanaka H, Tsukahara H. A novel mutation in the COL2A1 gene in a patient with Stickler syndrome type 1: a case report and review of the literature. J Med Case Rep. 2017;11:237. doi:10.1186/s13256-017-1396-y.
   PubMedGoogle Scholar
• Robin NH, Moran RT, Ala-Kokko L. Stickler syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, editors. GeneReviews((R)). Seattle: University of Washington, Seattle University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle; 1993. (All rights reserved).
   Google Scholar
• Melkoniemi M, Koillinen H, Mannikko M, Warman ML, Pihlajamaa T, Kaariainen H, Rautio J, Hukki J, Stofko JA, Cisneros GJ, et al. Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. Eur J Hum Genet. 2003;11:265–70. doi:10.1038/sj.ejhg.5200950.
   PubMed Web of Science ®Google Scholar
• Nikopensius T, Jagomagi T, Krjutskov K, Tammekivi V, Saag M, Prane I, Piekuse L, Akota I, Barkane B, Krumina A, et al. Genetic variants in COL2A1, COL11A2, and IRF6 contribute risk to nonsyndromic cleft palate. Birth Defects Res Part A Clin Mol Teratol. 2010;88:748–56. doi:10.1002/bdra.v88:9.
   PubMedGoogle Scholar
• Hoornaert KP, Vereecke I, Dewinter C, Rosenberg T, Beemer FA, Leroy JG, Bendix L, Björck E, Bonduelle M, Boute O, et al. Stickler syndrome caused by COL2A1 mutations: genotype-phenotype correlation in a series of 100 patients. Eur J Hum Genet. 2010;18:872–80. doi:10.1038/ejhg.2010.23.
   PubMed Web of Science ®Google Scholar
• Richards AJ, Laidlaw M, Meredith SP, Shankar P, Poulson AV, Scott JD, Snead MP. Missense and silent mutations in COL2A1 result in Stickler syndrome but via different molecular mechanisms. Hum Mutat. 2007;28:639. doi:10.1002/()1098-1004.
   PubMedGoogle Scholar
• Richards AJ, Laidlaw M, Whittaker J, Treacy B, Rai H, Bearcroft P, Baguley DM, Poulson A, Ang A, Scott JD, et al. High efficiency of mutation detection in type 1 stickler syndrome using a two-stage approach: vitreoretinal assessment coupled with exon sequencing for screening COL2A1. Hum Mutat. 2006;27:696–704. doi:10.1002/humu.v27:7.
   PubMed Web of Science ®Google Scholar
• Barbieri O, Astigiano S, Morini M, Tavella S, Schito A, Corsi A, Martino DD, Bianco P, Cancedda R, Garofalo S, et al. Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation. Am J Physiol Cell Physiol. 2003;285(6):C1504–12. doi:10.1152/ajpcell.00579.2002.
   PubMed Web of Science ®Google Scholar
• Li SW, Prockop DJ, Helminen H, Fassler R, Lapvetelainen T, Kiraly K, Peltarri A, Arokoski J, Lui H, Arita M, et al. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev. 1995;9(22):2821–30. doi:10.1101/gad.9.22.2821.
   PubMed Web of Science ®Google Scholar
• Vandenberg P, Khillan JS, Prockop DJ, Helminen H, Kontusaari S, Ala-Kokko L. Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc Natl Acad Sci U S A. 1991;88(17):7640–44. doi:10.1073/pnas.88.17.7640.
   PubMed Web of Science ®Google Scholar
• Metsaranta M, Garofalo S, Decker G, Rintala M, de Crombrugghe B, Vuorio E. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol. 1992;118:203–12. doi:10.1083/jcb.118.1.203.
   PubMed Web of Science ®Google Scholar
• Garofalo S, Vuorio E, Metsaranta M, Rosati R, Toman D, Vaughan J, Lozano G, Mayne R, Ellard J, Horton W, et al. Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A. 1991;88:9648–52. doi:10.1073/pnas.88.21.9648.
   PubMed Web of Science ®Google Scholar
• Savontaus M, Rintala-Jamsa M, Morko J, Ronning O, Metsaranta M, Vuorio E. Abnormal craniofacial development and expression patterns of extracellular matrix components in transgenic Del1 mice harboring a deletion mutation in the type II collagen gene. Orthod Craniofac Res. 2004;7:216–26. doi:10.1111/j.1601-6343.2004.00304.x.
   PubMedGoogle Scholar
• Lavrin IO, McLean W, Seegmiller RE, Olsen BR, Hay ED. The mechanism of palatal clefting in the Col11a1 mutant mouse. Arch Oral Biol. 2001;46:865–69. doi:10.1016/S0003-9969(01)00044-9.
   PubMed Web of Science ®Google Scholar
• Li Y, Lacerda DA, Warman ML, Beier DR, Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, Andrikopoulos K, Ramirez F, et al. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell. 1995;80(3):423–30. doi:10.1016/0092-8674(95)90492-1.
   PubMed Web of Science ®Google Scholar
• McGuirt WT, Prasad SD, Griffith AJ, Kunst HP, Green GE, Shpargel KB, Runge C, Huybrechts C, Mueller RF, Lynch E, et al. Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet. 1999;23(4):413–19. doi:10.1038/70516.
   PubMed Web of Science ®Google Scholar
• Li SW, Takanosu M, Arita M, Bao Y, Ren ZX, Maier A, Prockop DJ, Mayne R. Targeted disruption of Col11a2 produces a mild cartilage phenotype in transgenic mice: comparison with the human disorder otospondylomegaepiphyseal dysplasia (OSMED). Dev Dyn. 2001;222:141–52. doi:10.1002/()1097-0177.
   PubMed Web of Science ®Google Scholar
• Halper J, Kjaer M. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol. 2014;802:31–47.
   PubMed Web of Science ®Google Scholar
• Zollinger AJ, Smith ML. Fibronectin, the extracellular glue. Matrix Biol. 2017;60–61:27–37. doi:10.1016/j.matbio.2016.07.011.
   PubMed Web of Science ®Google Scholar
• Astrof S, Crowley D, Hynes RO. Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol. 2007;311:11–24. doi:10.1016/j.ydbio.2007.07.005.
   PubMed Web of Science ®Google Scholar
• Astrof S, Hynes RO. Fibronectins in vascular morphogenesis. Angiogenesis. 2009;12:165–75. doi:10.1007/s10456-009-9136-6.
   PubMed Web of Science ®Google Scholar
• Liang D, Wang X, Mittal A, Dhiman S, Hou SY, Degenhardt K, Astrof S. Mesodermal expression of integrin alpha5beta1 regulates neural crest development and cardiovascular morphogenesis. Dev Biol. 2014;395:232–44. doi:10.1016/j.ydbio.2014.09.014.
   PubMed Web of Science ®Google Scholar
• Wang X, Astrof S. Neural crest cell-autonomous roles of fibronectin in cardiovascular development. Development. 2016;143:88–100. doi:10.1242/dev.125286.
   PubMed Web of Science ®Google Scholar
• Galloway JL, Jones SJ, Mossey PA, Ellis IR. The control and importance of hyaluronan synthase expression in palatogenesis. Front Physiol. 2013;4:10. doi:10.3389/fphys.2013.00010.
   PubMed Web of Science ®Google Scholar
• Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Hurme T, Kvist M, Pelto-Huikko M, Kalimo H, Järvinen M. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci. 2003;116:857–66. doi:10.1242/jcs.00303.
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich JE. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest. 2001;107:785–90. doi:10.1172/JCI12609.
   PubMed Web of Science ®Google Scholar
• Sage EH. Regulation of interactions between cells and extracellular matrix: a command performance on several stages. J Clin Invest. 2001;107:781–83. doi:10.1172/JCI12683.
   PubMed Web of Science ®Google Scholar
• Chiquet M, Blumer S, Angelini M, Mitsiadis TA, Katsaros C. Mesenchymal remodeling during palatal shelf elevation revealed by extracellular matrix and F-actin expression patterns. Front Physiol. 2016;7:392. doi:10.3389/fphys.2016.00392.
   PubMed Web of Science ®Google Scholar
• Chen W, Kim MS, Shanbhag S, Arai A, VanRyzin C, McDonnell NB, Merke DP. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects. Am J Med Genet Part A. 2009;149a:2803–08. doi:10.1002/ajmg.a.v149a:12.
   PubMed Web of Science ®Google Scholar
• Merke DP, Chen W, Morissette R, Xu Z, Van Ryzin C, Sachdev V, Hannoush H, Shanbhag SM, Acevedo AT, Nishitani M, et al. Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2013;98(2):E379–87. doi:10.1210/jc.2012-3148.
   PubMed Web of Science ®Google Scholar
• Morissette R, Merke DP, McDonnell NB. Transforming growth factor-beta (TGF-beta) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome. Eur J Med Genet. 2014;57:95–102.
   PubMed Web of Science ®Google Scholar
• Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294(Pt 1):271–78. doi:10.1042/bj2940271.
   PubMedGoogle Scholar
• Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002;62:5358–64.
   PubMed Web of Science ®Google Scholar
• Kii I, Amizuka N, Minqi L, Kitajima S, Saga Y, Kudo A. Periostin is an extracellular matrix protein required for eruption of incisors in mice. Biochem Biophys Res Commun. 2006;342:766–72. doi:10.1016/j.bbrc.2006.02.016.
   PubMed Web of Science ®Google Scholar
• Rios HF, Ma D, Xie Y, Giannobile WV, Bonewald LF, Conway SJ, Feng JQ. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol. 2008;79(8):1480–90. doi:10.1902/jop.2008.070624.
   PubMed Web of Science ®Google Scholar
• Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, Rogers R, Chen Z, Maeda M, Kruzynska-Frejtag A, et al. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol. 2005;25:11131–44. doi:10.1128/MCB.25.24.11131-11144.2005.
   PubMed Web of Science ®Google Scholar
• Kitase Y, Yamashiro K, Fu K, Richman JM, Shuler CF. Spatiotemporal localization of periostin and its potential role in epithelial-mesenchymal transition during palatal fusion. Cells Tissues Organs. 2011;193:53–63. doi:10.1159/000320178.
   PubMed Web of Science ®Google Scholar
• Kruzynska-Frejtag A, Wang J, Maeda M, Rogers R, Krug E, Hoffman S, Markwald RR, Conway SJ. Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn. 2004;229(4):857–68. doi:10.1002/()1097-0177.
   PubMed Web of Science ®Google Scholar
• Yao Y. Laminin: loss-of-function studies. Cell Mol Life Sci. 2017;74:1095–115. doi:10.1007/s00018-016-2381-0.
   PubMed Web of Science ®Google Scholar
• Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004;20:255–84. doi:10.1146/annurev.cellbio.20.010403.094555.
   PubMed Web of Science ®Google Scholar
• Yamada T, Hirata A, Sasabe E, Yoshimura T, Ohno S, Kitamura N, Yamamoto T. TCDD disrupts posterior palatogenesis and causes cleft palate. J Cranio-maxillo-facial Surg. 2014;42:1–6. doi:10.1016/j.jcms.2013.01.024.
   PubMed Web of Science ®Google Scholar
• Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33:407–11. doi:10.1038/ng1116.
   PubMed Web of Science ®Google Scholar
• Iozzo RV, Schaefer L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol. 2015;42:11–55. doi:10.1016/j.matbio.2015.02.003.
   PubMed Web of Science ®Google Scholar
• Jakobsen LP, Borup R, Vestergaard J, Larsen LA, Lage K, Maroun LL, Kjaer I, Niemann CU, Andersen M, Knudsen MA, et al. Expression analyses of human cleft palate tissue suggest a role for osteopontin and immune related factors in palatal development. Exp Mol Med. 2009;41(2):77–85. doi:10.3858/emm.2009.41.2.010.
   PubMed Web of Science ®Google Scholar
• Singh GD, Moxham BJ, Langley MS, Waddington RJ, Embery G. Changes in the composition of glycosaminoglycans during normal palatogenesis in the rat. Arch Oral Biol. 1994;39:401–07. doi:10.1016/0003-9969(94)90170-8.
   PubMed Web of Science ®Google Scholar
• Brinkley LL, Morris-Wiman J. The role of extracellular matrices in palatal shelf closure. Curr Top Dev Biol. 1984;19:17–36.
   PubMed Web of Science ®Google Scholar
• Singh GD, Moxham BJ, Langley MS, Embery G. Glycosaminoglycan biosynthesis during 5-fluoro-2-deoxyuridine-induced palatal clefts in the rat. Arch Oral Biol. 1997;42:355–63. doi:10.1016/S0003-9969(97)00031-9.
   PubMed Web of Science ®Google Scholar
• Martinez-Alvarez C, Tudela C, Perez-Miguelsanz J, O’Kane S, Puerta J, Ferguson MW. Medial edge epithelial cell fate during palatal fusion. Dev Biol. 2000;220:343–57. doi:10.1006/dbio.2000.9644.
   PubMed Web of Science ®Google Scholar
• Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65–74. doi:10.1124/mol.62.1.65.
   PubMed Web of Science ®Google Scholar
• Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Robey PG, et al. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res. 2002;17:1180–89. doi:10.1359/jbmr.2002.17.7.1180.
   PubMed Web of Science ®Google Scholar
• Zhang YX, Mori T, Iseki K, Hagino S, Takaki H, Takeuchi M, Hikake T, Tase C, Murakawa M, Yokoya S, et al. Differential expression of decorin and biglycan genes during palatogenesis in normal and retinoic acid-treated mice. Dev Dyn. 2003;226(4):618–26. doi:10.1002/dvdy.10267.
   PubMed Web of Science ®Google Scholar
• Hammond NL, Brookes KJ, Dixon MJ. Ectopic hedgehog signaling causes cleft palate and defective osteogenesis. J Dent Res. 2018;97:1485–93.
   PubMed Web of Science ®Google Scholar
• Knudsen TB, Bulleit RF, Zimmerman EF. Histochemical localization of glycosaminoglycans during morphogenesis of the secondary palate in mice. Anat Embryol (Berl). 1985;173:137–42. doi:10.1007/BF00707312.
   PubMedGoogle Scholar
• Larsson KS. Studies on the closure of the secondary palate. IV. Autoradiographic and histochemical studies of mouse embryos from cortisone-treated mothers. Acta Morphol Neerl Scand. 1962;4:369–86.
   PubMedGoogle Scholar
• Witt RM, Hecht ML, Pazyra-Murphy MF, Cohen SM, Noti C, van Kuppevelt TH, Fuller M, Chan JA, Hopwood JJ, Seeberger PH, et al. Heparan sulfate proteoglycans containing a glypican 5 core and 2-O-sulfo-iduronic acid function as sonic hedgehog co-receptors to promote proliferation. J Biol Chem. 2013;288:26275–88. doi:10.1074/jbc.M112.438937.
   PubMed Web of Science ®Google Scholar
• Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (New York, NY). 1991;252:1705–08. doi:10.1126/science.1646484.
   Google Scholar
• Matsuo I, Kimura-Yoshida C. Extracellular modulation of fibroblast growth factor signaling through heparan sulfate proteoglycans in mammalian development. Curr Opin Genet Dev. 2013;23:399–407. doi:10.1016/j.gde.2013.02.004.
   PubMed Web of Science ®Google Scholar
• He H, Huang M, Sun S, Wu Y, Lin X. Epithelial heparan sulfate regulates sonic hedgehog signaling in lung development. PLoS Genet. 2017;13:e1006992. doi:10.1371/journal.pgen.1006992.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu H, Lan Y, Aronow BJ, Kalinichenko VV, Jiang R. A Shh-Foxf-Fgf18-Shh molecular circuit regulating palate development. PLoS Genet. 2016;12:e1005769. doi:10.1371/journal.pgen.1005769.
   PubMed Web of Science ®Google Scholar
• Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991;64:841–48. doi:10.1016/0092-8674(91)90512-W.
   PubMed Web of Science ®Google Scholar
• Rice R, Spencer-Dene B, Connor EC, Gritli-Linde A, McMahon AP, Dickson C, Thesleff I, Rice DPC. Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J Clin Invest. 2004;113:1692–700. doi:10.1172/JCI20384.
   PubMed Web of Science ®Google Scholar
• Han J, Mayo J, Xu X, Li J, Bringas P Jr., Maas RL, Rubenstein JLR, Chai Y. Indirect modulation of Shh signaling by Dlx5 affects the oral-nasal patterning of palate and rescues cleft palate in Msx1-null mice. Development. 2009;136(24):4225–33. doi:10.1242/dev.036723.
   PubMed Web of Science ®Google Scholar
• Snyder-Warwick AK, Perlyn CA, Pan J, Yu K, Zhang L, Ornitz DM. Analysis of a gain-of-function FGFR2 crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate. Proc Natl Acad Sci U S A. 2010;107:2515–20. doi:10.1073/pnas.0913985107.
   PubMed Web of Science ®Google Scholar
• Li C, Lan Y, Krumlauf R, Jiang R. Modulating Wnt signaling rescues palate morphogenesis in pax9 mutant mice. J Dent Res. 2017;96:1273–81. doi:10.1177/0022034517719865.
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673–87. doi:10.1016/S0092-8674(02)00971-6.
   PubMed Web of Science ®Google Scholar
• Turner CJ, Badu-Nkansah K, Crowley D, van der Flier A, Hynes RO. alpha5 and alphav integrins cooperate to regulate vascular smooth muscle and neural crest functions in vivo. Development. 2015;142:797–808. doi:10.1242/dev.117572.
   PubMed Web of Science ®Google Scholar
• Zhu J, Motejlek K, Wang D, Zang K, Schmidt A, Reichardt LF. beta8 integrins are required for vascular morphogenesis in mouse embryos. Development. 2002;129:2891–903.
   PubMed Web of Science ®Google Scholar
• Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM, Ginsberg MH, Calderwood DA. Talin binding to integrin beta tails: a final common step in integrin activation. Science (New York, NY). 2003;302:103–06. doi:10.1126/science.1086652.
   Google Scholar
• Calderwood DA, Fujioka Y, de Pereda JM, Garcia-Alvarez B, Nakamoto T, Margolis B, McGlade CJ, Liddington RC, Ginsberg MH. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A. 2003;100:2272–77. doi:10.1073/pnas.262791999.
   PubMed Web of Science ®Google Scholar
• Senetar MA, McCann RO. Gene duplication and functional divergence during evolution of the cytoskeletal linker protein talin. Gene. 2005;362:141–52. doi:10.1016/j.gene.2005.08.012.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhang J, Koh W, Yu Q, Zhu X, Amsterdam A, Davis GE, Arnaout MA, Xiong JW. Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish. FASEB J. 2015;29:4989–5005. doi:10.1096/fj.15-273409.
   PubMed Web of Science ®Google Scholar
• Ishii K, Mukherjee K, Okada T, Liao EC. Genetic requirement of talin1 for proliferation of cranial neural crest cells during palate development. Prs-Glob Open. 2018;6:e1633.
   Google Scholar
• Monkley SJ, Zhou XH, Kinston SJ, Giblett SM, Hemmings L, Priddle H, Brown JE, Pritchard CA, Critchley DR, Fässler R. Disruption of the talin gene arrests mouse development at the gastrulation stage. Dev Dyn. 2000;219:560–74. doi:10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y.
   PubMed Web of Science ®Google Scholar
• Debrand E, Conti FJ, Bate N, Spence L, Mazzeo D, Pritchard CA, Monkley SJ, Critchley DR. Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. Biochem Biophys Res Commun. 2012;426(2):190–95. doi:10.1016/j.bbrc.2012.08.061.
   PubMed Web of Science ®Google Scholar
• Morris-Wiman J, Burch H, Basco E. Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis. Anat Embryol (Berl). 2000;202:129–41. doi:10.1007/s004290000098.
   PubMedGoogle Scholar
• Morris-Wiman J, Du Y, Brinkley L. Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis. J Craniofac Genet Dev Biol. 1999;19:201–12.
   PubMedGoogle Scholar
• de Oliveira Demarchi AC, Zambuzzi WF, Paiva KB, da Silva-valenzuela M, Nunes FD, de Cassia Savio Figueira R, Sasahara RM, Demasi MAA, Winnischofer SMB, Sogayar MC, et al. Development of secondary palate requires strict regulation of ECM remodeling: sequential distribution of RECK, MMP-2, MMP-3, and MMP-9. Cell Tissue Res. 2010;340:61–69. doi:10.1007/s00441-010-0931-6.
   PubMed Web of Science ®Google Scholar
• Mansell JP, Kerrigan J, McGill J, Bailey J, TeKoppele J, Sandy JR. Temporal changes in collagen composition and metabolism during rodent palatogenesis. Mech Ageing Dev. 2000;119:49–62. doi:10.1016/S0047-6374(00)00168-8.
   PubMed Web of Science ®Google Scholar
• Smane-Filipova L, Pilmane M, Akota I. MMPs and TIMPs expression in facial tissue of children with cleft lip and palate. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160:538–42. doi:10.5507/bp.2016.055.
   PubMed Web of Science ®Google Scholar
• Blavier L, Lazaryev A, Groffen J, Heisterkamp N, DeClerck YA, Kaartinen V. TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell. 2001;12:1457–66. doi:10.1091/mbc.12.5.1457.
   PubMed Web of Science ®Google Scholar
• Brown NL, Yarram SJ, Mansell JP, Sandy JR. Matrix metalloproteinases have a role in palatogenesis. J Dent Res. 2002;81:826–30. doi:10.1177/154405910208101206.
   PubMed Web of Science ®Google Scholar
• Shi J, Son MY, Yamada S, Szabova L, Kahan S, Chrysovergis K, Wolf L, Surmak A, Holmbeck K. Membrane-type MMPs enable extracellular matrix permissiveness and mesenchymal cell proliferation during embryogenesis. Dev Biol. 2008;313:196–209. doi:10.1016/j.ydbio.2007.10.017.
   PubMed Web of Science ®Google Scholar
• Brown GD, Nazarali AJ. Matrix metalloproteinase-25 has a functional role in mouse secondary palate development and is a downstream target of TGF-beta3. BMC Dev Biol. 2010;10:93. doi:10.1186/1471-213X-10-93.
   PubMed Web of Science ®Google Scholar
• Kondo H, Matsushita I, Nagata T, Hayashi T, Kakinoki M, Uchio E, Kondo M, Ohji M, Kusaka S. Novel mutations in the COL2A1 gene in Japanese patients with Stickler syndrome. Hum Genome Var. 2016;3(1):16018. doi:10.1038/hgv.2016.18.
   PubMedGoogle Scholar
• Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet. 2011;12:167–78. doi:10.1038/nrg2933.
   PubMed Web of Science ®Google Scholar
• Kannu P, Bateman J, Savarirayan R. Clinical phenotypes associated with type II collagen mutations. J Paediatr Child Health. 2012;48:E38–43. doi:10.1111/j.1440-1754.2010.01979.x.
   PubMedGoogle Scholar
• Fairfield H, Gilbert GJ, Barter M, Corrigan RR, Curtain M, Ding Y, D’Ascenzo M, Gerhardt DJ, He C, Huang W, et al. Mutation discovery in mice by whole exome sequencing. Genome Biol. 2011;12:R86. doi:10.1186/gb-2011-12-9-r86.
   PubMed Web of Science ®Google Scholar
• Miller WL, Merke DP. Tenascin-X, congenital adrenal hyperplasia, and the CAH-X syndrome. Horm Res Paediatr. 2018;89:352–61. doi:10.1159/000481911.
   PubMed Web of Science ®Google Scholar
• O’Connell M, Burrows NP, van Vlijmen-willems MJ, Clark SM, Schalkwijk J. Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature. Br J Dermatol. 2010;163:1340–45. doi:10.1111/j.1365-2133.2010.09949.x.
   PubMed Web of Science ®Google Scholar
• Kimata K, Barrach HJ, Brown KS, Pennypacker JP. Absence of proteoglycan core protein in cartilage from the cmd/cmd (Cartilage matrix deficiency) mouse. J Biol Chem. 1981;256:6961–68.
   PubMed Web of Science ®Google Scholar
• Krueger RC Jr., Kurima K, Schwartz NB. Completion of the mouse aggrecan gene structure and identification of the defect in the cmd-Bc mouse as a near complete deletion of the murine aggrecan gene. Mamm Genome. 1999;10:1119–25. doi:10.1007/s003359901176.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Kurisu K. Effect of triamcinolone acetonide on proliferation and collagen and glycosaminoglycan syntheses in palatal mesenchymal cells from the mouse fetus. J Craniofac Genet Dev Biol. 1983;3:351–69.
   PubMedGoogle Scholar
• Foreman DM, Sharpe PM, Ferguson MW. Comparative biochemistry of mouse and chick secondary-palate development in vivo and in vitro with particular emphasis on extracellular matrix molecules and the effects of growth factors on their synthesis. Arch Oral Biol. 1991;36:457–71. doi:10.1016/j.ejmg.2013.12.004.
   PubMed Web of Science ®Google Scholar
• Jin JZ, Tan M, Warner DR, Darling DS, Higashi Y, Gridley T, Ding J. Mesenchymal cell remodeling during mouse secondary palate reorientation. Dev Dyn. 2010;239:2110–17. doi:10.1002/dvdy.22339.
   PubMed Web of Science ®Google Scholar